Hello E-pao Team
Recently there has been an outbreak of an Acute Illness which started in Vietnam, Thailand, Hongkong and
Singapore with sporadic cases occuring in the Western Countries as well.
The exact cause or etiology of this illness is not known yet. It is thought to be caused by a Virus which
come under the family of Paramyxovirus which also comprises of common viruses that causes mumps and measles.
This acute illness has been termed as Severe Acute Respiratory Syndrome.
It is difficult to determine how significant this condition is in a place like Manipur.
Thailand is not far away from Manipur. Healthcare professionals will find this note useful even
though it is just the preliminary clinical description
Preliminary Clinical Description of Severe Acute Respiratory Syndrome
Severe acute respiratory syndrome (SARS) is a condition of unknown etiology that has been described in patients
in Asia, North America, and Europe. This report summarizes the clinical description of patients with SARS based on
information collected since mid-February 2003 by the World Health Organization (WHO), Health Canada,
and CDC in collaboration with health authorities and clinicians in Hong Kong, Taiwan, Bangkok,
Singapore, the United Kingdom, Slovenia, Canada, and the United States. This information is preliminary
and limited by the broad and necessarily nonspecific case definition.
As of March 21, 2003, the majority of patients identified as having SARS have been adults aged 25--70 years
who were previously healthy. Few suspected cases of SARS have been reported among children aged < 15 years.
The incubation period for SARS is typically 2--7 days; however, isolated reports have suggested an incubation period
as long as 10 days. The illness begins generally with a prodrome of fever ( > 100.4°F [ > 38.0°C]).
Fever often is high, sometimes is associated with chills and rigors, and might be accompanied by other symptoms,
including headache, malaise, and myalgia. At the onset of illness, some persons have mild respiratory symptoms.
Typically, rash and neurologic or gastrointestinal findings are absent; however, some patients have
reported diarrhea during the febrile prodrome.
After 3--7 days, a lower respiratory phase begins with the onset of a dry, nonproductive cough or dyspnea,
which might be accompanied by or progress to hypoxemia. In 10%--20% of cases, the respiratory illness is
severe enough to require intubation and mechanical ventilation.
The case-fatality rate among persons with illness meeting the current WHO case definition
of SARS is approximately 3%.
Chest radiographs might be normal during the febrile prodrome and throughout the course of illness.
However, in a substantial proportion of patients, the respiratory phase is characterized by early focal
interstitial infiltrates progressing to more generalized, patchy, interstitial infiltrates.
Some chest radiographs from patients in the late stages of SARS also have shown areas of consolidation.
Early in the course of disease, the absolute lymphocyte count is often decreased. Overall white blood cell counts have
generally been normal or decreased. At the peak of the respiratory illness, approximately 50% of
patients have leukopenia and thrombocytopenia or low-normal platelet counts (50,000--150,000/µL).
Early in the respiratory phase, elevated creatine phosphokinase levels (as high as 3,000 IU/L) and
hepatic transaminases (two to six times the upper limits of normal) have been noted.
In the majority of patients, renal function has remained normal.
The severity of illness might be highly variable, ranging from mild illness to death. Although a few close
contacts of patients with SARS have developed a similar illness, the majority have remained well.
Some close contacts have reported a mild, febrile illness without respiratory signs or symptoms, suggesting
the illness might not always progress to the respiratory phase.
Treatment regimens have included several antibiotics to presumptively treat known bacterial agents of
atypical pneumonia. In several locations, therapy also has included antiviral agents such as oseltamivir
or ribavirin. Steroids have also been administered orally or intravenously to patients in
combination with ribavirin and other antimicrobials. At present, the most efficacious treatment
regimen, if any, is unknown.
In the United States, clinicians who suspect cases of SARS are requested to report such cases
to their state health departments. CDC requests that reports of suspected cases from state health departments,
international airlines, cruise ships, or cargo carriers be directed to the SARS Investigative Team
at the CDC Emergency Operations Center, telephone 770-488-7100. Outside the United States, clinicians
who suspect cases of SARS are requested to report such cases to their local public health authorities.
Additional information about SARS (e.g., infection control guidance and procedures for reporting suspected cases)
is available at http://www.cdc.gov/ncidod/sars .
Global case counts are available at http://www.who.int .
Baharul Islam is a Chest Physician working in the UK.
He can be reach at [email protected]
|